(NASDAQ: PLUR) Pluri's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 41.39%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 100.55%.
Pluri's earnings in 2025 is -$22,583,000.On average, 4 Wall Street analysts forecast PLUR's earnings for 2026 to be -$22,461,481, with the lowest PLUR earnings forecast at -$21,580,638, and the highest PLUR earnings forecast at -$23,122,113.
In 2027, PLUR is forecast to generate -$15,806,227 in earnings, with the lowest earnings forecast at -$15,186,375 and the highest earnings forecast at -$16,271,116.